Hepcidin, a key regulator of iron metabolism and mediator of anemia of inflammation.

Human hepcidin, a 25-amino acid peptide made by hepatocytes, may be a new mediator of innate immunity and the long-sought iron-regulatory hormone. The synthesis of hepcidin is greatly stimulated by inflammation or by iron overload. Evidence from transgenic mouse models indicates that hepcidin is the predominant negative regulator of iron absorption in the small intestine, iron transport across the placenta, and iron release from macrophages. The key role of hepcidin is confirmed by the presence of nonsense mutations in the hepcidin gene, homozygous in the affected members, in 2 families with severe juvenile hemochromatosis. Recent evidence shows that deficient hepcidin response to iron loading may contribute to iron overload even in the much milder common form of hemochromatosis, from mutations in the HFE gene. In anemia of inflammation, hepcidin production is increased up to 100-fold and this may account for the defining feature of this condition, sequestration of iron in macrophages. The discovery of hepcidin and its role in iron metabolism could lead to new therapies for hemochromatosis and anemia of inflammation.

[1]  P. Gros,et al.  Divalent-metal transport by NRAMP proteins at the interface of host-pathogen interactions. , 2001, Trends in microbiology.

[2]  D. Purdie,et al.  Disrupted hepcidin regulation in HFE-associated haemochromatosis and the liver as a regulator of body iron homoeostasis , 2003, The Lancet.

[3]  M. Loda,et al.  Inappropriate expression of hepcidin is associated with iron refractory anemia: implications for the anemia of chronic disease. , 2002, Blood.

[4]  N. Andrews,et al.  Mammalian iron transport: an unexpected link between metal homeostasis and host defense. , 1998, Journal of Laboratory and Clinical Medicine.

[5]  R. Crystal.  Managed care for viruses , 1997, Nature Medicine.

[6]  V. Felitti,et al.  A study of genes that may modulate the expression of hereditary hemochromatosis: transferrin receptor-1, ferroportin, ceruloplasmin, ferritin light and heavy chains, iron regulatory proteins (IRP)-1 and -2, and hepcidin. , 2001, Blood cells, molecules & diseases.

[7]  P. Bárány.  Inflammation, serum C-reactive protein, and erythropoietin resistance. , 2001, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[8]  Jennifer J. Pointon,et al.  A valine deletion of ferroportin 1: a common mutation in hemochromastosis type 4. , 2002, Blood.

[9]  R. Ellison.  The effects of lactoferrin on gram-negative bacteria. , 1994, Advances in experimental medicine and biology.

[10]  G. Cairo,et al.  Iron regulatory proteins in pathobiology. , 2000, The Biochemical journal.

[11]  D. Girelli,et al.  Mutant antimicrobial peptide hepcidin is associated with severe juvenile hemochromatosis , 2003, Nature Genetics.

[12]  C. Beaumont,et al.  Severe iron deficiency anemia in transgenic mice expressing liver hepcidin , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[13]  S. Vaulont,et al.  Essential Role in Vivo of Upstream Stimulatory Factors for a Normal Dietary Response of the Fatty Acid Synthase Gene in the Liver* , 1999, The Journal of Biological Chemistry.

[14]  Christina H. Park,et al.  Hepcidin, a Urinary Antimicrobial Peptide Synthesized in the Liver* , 2001, The Journal of Biological Chemistry.

[15]  N. Solanky,et al.  Effect of iron deficiency on placental transfer of iron and expression of iron transport proteins in vivo and in vitro. , 2001, The Biochemical journal.

[16]  W. Sly,et al.  Hepcidin: A putative iron-regulatory hormone relevant to hereditary hemochromatosis and the anemia of chronic disease , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[17]  Bruno Turlin,et al.  A New Mouse Liver-specific Gene, Encoding a Protein Homologous to Human Antimicrobial Peptide Hepcidin, Is Overexpressed during Iron Overload* , 2001, The Journal of Biological Chemistry.

[18]  E. Beutler,et al.  Seeking candidate mutations that affect iron homeostasis. , 2002, Blood cells, molecules & diseases.

[19]  J. Burns,et al.  Bass hepcidin is a novel antimicrobial peptide induced by bacterial challenge. , 2002, European journal of biochemistry.

[20]  P. Grammatico,et al.  Absence of hepcidin gene mutations in 10 Italian patients with primary iron overload. , 2002, Haematologica.

[21]  V. Braun,et al.  Bacterial solutions to the iron-supply problem. , 1999, Trends in biochemical sciences.

[22]  W. Forssmann,et al.  Chemical synthesis of beta-defensins and LEAP-1/hepcidin. , 2002, The journal of peptide research : official journal of the American Peptide Society.

[23]  N. Andrews.  Metal transporters and disease. , 2002, Current opinion in chemical biology.

[24]  N. Andrews,et al.  Disorders of iron metabolism. , 1999, The New England journal of medicine.

[25]  N. Andrews,et al.  Microcytic anaemia mice have a mutation in Nramp2, a candidate iron transporter gene , 1997, Nature genetics.

[26]  T. Cox,et al.  Hemochromatosis--neonatal and young subjects. , 2002, Blood cells, molecules & diseases.

[27]  J. Gitlin,et al.  Targeted gene disruption reveals an essential role for ceruloplasmin in cellular iron efflux. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[28]  L. Powell,et al.  Novel mutation in ferroportin1 is associated with autosomal dominant hemochromatosis. , 2002, Blood.

[29]  H. Vogel,et al.  The Solution Structure of Human Hepcidin, a Peptide Hormone with Antimicrobial Activity That Is Involved in Iron Uptake and Hereditary Hemochromatosis* 210 , 2002, The Journal of Biological Chemistry.

[30]  Elizabeta Nemeth,et al.  Hepcidin, a putative mediator of anemia of inflammation, is a type II acute-phase protein. , 2003, Blood.

[31]  C. Enns,et al.  Iron homeostasis: new tales from the crypt. , 2000, Blood.

[32]  T. Rouault,et al.  Association of pulmonary tuberculosis with increased dietary iron. , 2001, The Journal of infectious diseases.

[33]  Gaël Nicolas,et al.  The gene encoding the iron regulatory peptide hepcidin is regulated by anemia, hypoxia, and inflammation. , 2002, The Journal of clinical investigation.

[34]  C. Beaumont,et al.  Lack of hepcidin gene expression and severe tissue iron overload in upstream stimulatory factor 2 (USF2) knockout mice , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[35]  R. Jurado.  Iron, infections, and anemia of inflammation. , 1997, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[36]  W. Sly,et al.  Decreased liver hepcidin expression in the Hfe knockout mouse. , 2002, Blood cells, molecules & diseases.

[37]  Peter Schulz-Knappe,et al.  LEAP‐1, a novel highly disulfide‐bonded human peptide, exhibits antimicrobial activity , 2000, FEBS letters.

[38]  M. Worwood,et al.  Autosomal dominant reticuloendothelial iron overload associated with a 3-base pair deletion in the ferroportin 1 gene (SLC11A3). , 2002, Blood.

[39]  Marcel E Conrad,et al.  Pathways of iron absorption. , 2002, Blood cells, molecules & diseases.

[40]  Andrew T McKie,et al.  Hepcidin expression inversely correlates with the expression of duodenal iron transporters and iron absorption in rats. , 2002, Gastroenterology.

[41]  E. Greenberg,et al.  A component of innate immunity prevents bacterial biofilm development , 2002, Nature.

[42]  H. Collins.  The role of iron in infections with intracellular bacteria. , 2003, Immunology letters.

[43]  D. Gilot,et al.  C/EBPα Regulates Hepatic Transcription of Hepcidin, an Antimicrobial Peptide and Regulator of Iron Metabolism , 2002, The Journal of Biological Chemistry.

[44]  W. Forssmann,et al.  Chemical synthesis of β-defensins and LEAP-1/hepcidin , 2002 .

[45]  P. Aisen,et al.  Chemistry and biology of eukaryotic iron metabolism. , 2001, The international journal of biochemistry & cell biology.

[46]  W. Sly,et al.  Ferroportin mutation in autosomal dominant hemochromatosis: loss of function, gain in understanding. , 2001, The Journal of clinical investigation.

[47]  A. Donovan,et al.  Autosomal-dominant hemochromatosis is associated with a mutation in the ferroportin (SLC11A3) gene. , 2001, The Journal of clinical investigation.